Drug repurposing using transcriptome sequencing and virtual drug screening in a patient with glioblastoma

Conclusions In conclusion, we identified novel small molecules via a drug repurposing approach that could be effectively used for personalized glioblastoma therapy especially for patients carrying BRAF47-438del and PIK3R1-G376R mutations.
Source: Investigational New Drugs - Category: Drugs & Pharmacology Source Type: research